Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares U.S. Healthcare ETF (IYH) and VanEck Biotech ETF (BBH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. IYH is more expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.35% for BBH. IYH is down -3.73% year-to-date (YTD) with -$496M in YTD flows. BBH performs better with 1.49% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of IYH and BBH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IYH BBH | -3.77%-1.90% | -3.07%+0.58% | -3.73%+1.49% | +4.93%+19.17% | +23.35%+25.33% | +33.50%+12.69% |
| Flows | IYH BBH | -$238M-$2M | -$580M-$2M | -$496M-$2M | -$322M-$58M | -$643M-$190M | -$164M-$121M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IYH BBH | +14.25%+19.85% | +17.79%+22.37% | +13.83%+18.42% | +14.74%+21.47% |
| Max drawdown | IYH BBH | -6.97%-6.07% | -12.43%-14.98% | -17.89%-22.78% | -17.89%-39.88% |
| Max drawdown duration | IYH BBH | 64d43d | 211d128d | 445d440d | 445d1675d |
IYH | BBH | |
Last sale 3/12/2026 at 1:30 PM | $62.65 | $187.02 |
| Previous close 03/12/2026 | $63.88 | $192.04 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IYH | BBH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IYH | BBH | |
|---|---|---|
| Last price | $62.65 | $187.02 |
| 1D performance | -1.93% | -2.61% |
| AuM | $2.96 B | $379.50 M |
| E/R | 0.38% | 0.35% |
IYH | BBH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | iShares | VanEck |
| Benchmark | Russell 1000 Health Care RIC 22.5/45 Capped Gross Index | MVIS US Listed Biotech 25 Index |
| N° of holdings | 96 | 22 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 12, 2000 | December 20, 2011 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
